Ann Child Neurol.
2021 Jan;29(1):43-46. 10.26815/acn.2020.00227.
Precision Medicine Based on High-Throughput Nucleotide Sequencing for a Patient with SCN2A-Related Developmental Epileptic Encephalopathy
- Affiliations
-
- 1Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- 2Department of Pediatrics, CHA Gangnam Medical Center, CHA University, Seoul, Korea
- KMID: 2509917
- DOI: http://doi.org/10.26815/acn.2020.00227
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Frequently Identified Genetic Developmental and Epileptic Encephalopathy: A Review Focusing on Precision Medicine
- Early-onset epileptic encephalopathies and the diagnostic approach to underlying causes
- Ketogenic Diet in Infants with Early-Onset Epileptic Encephalopathy and SCN2A Mutation
- The Cancer Precision Medicine Diagnosis and Treatment (K-MASTER) Enterprise
- Advantages of the single nucleotide polymorphism-based noninvasive prenatal test
